Study Identifies PIEZO1-VEGFR2 Interaction as Key Regulator of Vascular Repair in Arteriovenous Fistulas
Researchers have identified that a mechanical force-sensing protein complex, PIEZO1-VEGFR2, governs how CD34+ progenitor cells differentiate into mature endothelial cells to repair arteriovenous fistulas (AVFs). The study used single-cell RNA sequencing, mouse knockout models, and cell culture experiments to show that laminar blood flow promotes healthy endothelial maturation via this complex, while disturbed oscillatory flow impairs it. The findings suggest that pharmacologically activating the downstream AKT signaling pathway could reduce neointimal hyperplasia, a major cause of AVF failure in dialysis patients.
A preprint study posted to bioRxiv reports that the mechanosensory protein PIEZO1 physically interacts with the vascular growth factor receptor VEGFR2 to regulate how CD34+ progenitor cells repair damaged endothelium in arteriovenous fistulas. Using single-cell RNA sequencing of both human and mouse AVF tissue, the researchers found high concentrations of CD34-expressing cells in the vessel wall. Laboratory experiments showed that laminar shear stress drives these cells toward endothelial maturity—upregulating markers like VE-cadherin and claudin-5—while oscillatory, disturbed flow has the opposite effect. Mechanistically, the PIEZO1-VEGFR2 complex was found to mediate these divergent responses through the AKT-FoxO1 signaling axis. In a conditional mouse model where Piezo1 was deleted specifically in CD34+ cells, AVFs showed fewer CD34-derived endothelial cells, more compact tissue arrangement, and reduced neointimal hyperplasia. Importantly, pharmacological activation of AKT signaling in the mouse AVF model enhanced CD34+ cell-mediated repair and also attenuated neointimal hyperplasia, pointing to a potential therapeutic strategy. Because AVF dysfunction is a leading cause of morbidity in hemodialysis patients, these mechanistic insights could have significant clinical relevance.
What's missing
As a preprint, this study has not yet undergone formal peer review, so findings should be interpreted with caution. The study does not address whether the PIEZO1-VEGFR2 interaction or AKT-targeted therapies would be safe or effective in human patients, nor does it discuss potential off-target effects of pharmacological AKT activation. Long-term outcomes of AKT activation in vivo were not reported.
What different sources said
- bioRxivCenter
Mechano-Initiated PIEZO1-VEGFR2 Interaction Governs CD34+ Cell Differentiation and Repair in Arteriovenous Fistula
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.